Charlottesville, VA — April 25, 2025 — Contraline, Inc., the company pioneering male contraception, is proud to announce that it has won 1st place at the 2025 American Urological Association (AUA) Innovation Nexus, receiving the prestigious Founders’ Circle Urology Advancement Award.

Selected as the most innovative company in urology, Contraline was recognized for its groundbreaking presentation, “Contraline: The Male Contraception Company,” which showcased the company's novel approaches to reversible male birth control.

“We’re honored to be recognized by the AUA and the Innovation Nexus community,” said Kevin Eisenfrats, CEO of Contraline. “This award reflects the growing momentum for innovation in male reproductive health and the tremendous support we’ve received from the urology field.”

The AUA Innovation Nexus brings together leading clinicians, researchers, executives, and investors to spotlight companies redefining urologic care. Contraline’s selection as the top awardee underscores its potential to transform reproductive medicine.